Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00389948 · ClinicalTrials.gov registry record · Phase 3
Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
A Phase 3 study of Heartburn, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 576
- Enrollment target
- 20
- Study locations
NCT00389948 is a Phase 3 study of Heartburn that has completed, run by Novartis. The registered enrollment target is 576 participants, above the 356-participant average among 9 other Heartburn trials with a reported enrollment target (62% higher). The trial reports 20 study locations across 15 states.
The verdict
NCT00389948, a Phase 3 study of Heartburn, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 576 participants
- Enrollment target
- 20
- Study locations
Study Summary
Heartburn, a burning sensation in the chest or throat, occurs in many patients when acidic stomach contents move into the esophagus from the stomach. This study will investigate the safety and efficacy of lansoprazole 15 mg once a day in treating frequent heartburn.
Conditions Studied
Interventions
- DRUG Lanzoprazole
Study Locations (20)
Florida
- Eastern Research - Hialeah
- Health Awareness Inc. - Jupiter
- Miami Research Associates - Miami
Alabama
- Clinical Research Consultants Inc. - Hoover
- - Huntsville
California
- California Bio Medical Research Institute - Los Angeles
- Allergy Medical Group of North Area - Roseville
Georgia
- Radiant Research - Atlanta
- Radiant Research - Atlanta
Arizona
- Radiant Research - Sierra Vista
Indiana
- - Evansville
Maryland
- Clinical Associates - Reisterstown
Missouri
- Medex Healthcare Research, Inc. - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 576 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00389948
The ClinicalTrials.gov registry entry for NCT00389948 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 576 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 356-participant average among 9 other Heartburn trials with a reported enrollment target (62% higher). The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heartburn appearing as the primary indexed condition, and to 1 intervention - of which Lanzoprazole is the first listed.
NCT00389948 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Florida, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT00389948 about?
NCT00389948 is a clinical study titled "Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn". Heartburn, a burning sensation in the chest or throat, occurs in many patients when acidic stomach contents move into the esophagus from the stomach. This study will investigate the safety and efficacy of lansoprazole 15 mg once a day in treating frequent heartburn.
What is the current status of trial NCT00389948?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 576 participants. The study started on 2006-06. Estimated completion is 2007-01.
What conditions does trial NCT00389948 study?
This clinical trial studies the following conditions: Heartburn.
What interventions are being tested in trial NCT00389948?
The interventions under investigation include: Lanzoprazole (DRUG).
Who is sponsoring clinical trial NCT00389948?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00389948 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heartburn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Domperidone in Treating Patients With Gastrointestinal Disorders
RECRUITING · Phase 3
-
E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
COMPLETED · Phase 3
-
E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
COMPLETED · Phase 3
-
Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
COMPLETED · Phase 3
-
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
RECRUITING · NA
-
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.